Depression - Major Depressive Disorder
196
77
91
30
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 196 trials
100.0%
+13.4% vs benchmark
5%
10 trials in Phase 3/4
3%
1 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 30 completed trials
Clinical Trials (196)
Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders
iPath for CP Pilot
Slow-Paced Breathing and Electrical Vagus Nerve Stimulation as Add-on Treatments for Depression
Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression
PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low Mood
Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
tDCS for Late-Life Depression
Biomarker-Guided Antidepressant Selection
Mobile Cognitive Behavioral Therapy in Early Stroke Recovery
Singula Phase 0.1 Primary Care Pilot
The Medically Tailored Groceries and Mental Health Study
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)
ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder
Lumateperone for Late-Life Depression
Longitudinal Effects of Brain Stimulation on Decision-Making and Reward Learning
Characterizing Synaptic Density in Treatment Resistant Depression
An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.
Meditative Neurofeedback for Depression
Evaluating the Effects of StrongMinds Community-Based Group Interpersonal Therapy on Depression and Secondary Outcomes in Uganda